NRIP1
NRIP1 (Nuclear Receptor Interacting Protein 1), also known as RIP140, is a protein that in humans is encoded by the NRIP1 gene. It is a nuclear protein that specifically interacts with the hormone-dependent activation function AF-2 of nuclear receptors.
Function[edit | edit source]
NRIP1 is known to regulate the transcriptional activity of various nuclear receptors by affecting their ligand-dependent transcription activity. It is involved in the regulation of several physiological processes, including metabolic and inflammatory responses, cell differentiation, and apoptosis.
Structure[edit | edit source]
The NRIP1 protein is composed of 1158 amino acids and has a molecular weight of approximately 130 kDa. It contains several leucine-rich repeats (LRRs) and a carboxy-terminal domain, which are essential for its interaction with nuclear receptors.
Clinical significance[edit | edit source]
Alterations in the expression of NRIP1 have been associated with various diseases, including obesity, type 2 diabetes, and cancer. In particular, overexpression of NRIP1 has been observed in several types of cancer, suggesting a potential role in tumorigenesis.
Research[edit | edit source]
Current research is focused on understanding the precise role of NRIP1 in disease progression and exploring its potential as a therapeutic target.
See also[edit | edit source]
References[edit | edit source]
Translate: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD